Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.7800
0.00 (0.00%)
Jun 27, 2025, 2:48 PM EDT
73.33%
Market Cap 62.02M
Revenue (ttm) n/a
Net Income (ttm) -4.07M
Shares Out 76.57M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,500
Average Volume 2,375
Open 0.7800
Previous Close 0.7800
Day's Range 0.7800 - 0.7800
52-Week Range 0.2800 - 1.2500
Beta 0.58
RSI 32.41
Earnings Date May 30, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.